News & Events

Read article about ElMindA published in Forbes Israel magazine, February 2012 issue

The Wonders of our Mind

Neuroscience

 Receiving a Transmission from the Brain

ElMindA is developing a tool that measures our brain’s electrical fields and signals during brain activity, in order to enable brain-disorder diagnosis and treatment in real time

 

One  of  the  most  important  discoveries  in  neuroscience  –  perhaps  the  final  frontier  for  medical science  specifically  and  for  science  in  general  –  is  the  degree  to  which  the  brain  works  as  a synchronized,  organized  system  rather  than  as  isolated  regions.  Another  no  less  important discovery is that the brain is largely flexible and plastic, a fact that gives much hope in regard to its healing abilities. And  yet, compared to most fields of modern medicine, such as cardiology, orthopedics  and  gynecology,  in  which  diagnosis,  treatment  and  follow-up  all  rely  on  precise measuring equipment (ultrasound, CT, etc.), the fields of medicine dealing with the brain – such as psychiatry and neurology – are forced to operate under vague, uncertain conditions in terms of the quality of diagnosis and the efficacy of care.

What  is  it:  The  goal  of  the  research  conducted  by  Professor  Amir  Geva  over  the  last  thirty years, and by the ElMindA Corporation, over the last six years, was to bring modern medicine to the brain by developing an imaging and treatment tool that would enable measuring and tracking of  the  network  activities  of  high  neural  processes  such  as  memory  and  identification,  clear presentation  of  the  information  to  the  attending  physician  and,  when  necessary,  repairing  and improvement  of  neural  network  processes  using  external  or  internal  stimulus  adjusted  to measurement. This may improve the lives of one third of the world’s population who suffer from various brain-related illnesses. 

It has been known for some time that the brain is composed of complex networks of neurons that work  together  in  time  and  space  to  perform  complex  tasks,  such  as  processing  and  identifying sensory  input,  long-  and  short-term  memory  storage,  attention,  and  abstract  thinking,  but  it  is very difficult to measure this activity.

How does it work: The company’s technology is based on measuring the electrical fields that are created through the brain’s neural electrical activity on the scalp and around the head during the performance of various cognitive tasks, and then reevaluating the relevant active neural network in  terms  of  time  and  location  in  the  brain,  using  advanced  methods  of  signal  processing  and pattern recognition taken from engineering and computer science research.

The  brain  behind  it:  Professor  Geva,  together  with  Goded  Shahaf  and  Ronen  Gadot,  set  up ElMinda  in  2006,  with  the  purpose  of  measuring  network  activities  of  the  functional  and dysfunctional  human  brain  during  performance  of  various  cognitive  tasks,  to  enable  diagnosis and treatment of brain disorders while tracking changes in the network activity accordingly.

Status:  The  company  is  currently  involved  in  various  stages  of  the  complex  and  expensive process of developing drugs with leading teams from the largest pharmaceutical corporations in the world. The goal of this process is to measure and understand the effects of the drugs on the human brain’s network activities, and thus to develop new and effective drugs whose effects on the  human  brain  are  known  and  measured  and  which  could  be  used  to  treat  disorders  such  as Parkinson’s,  Alzheimer’s,  ADHD,  schizophrenia,  pain,  depression  and  more.  The  company  is concurrently  working  to  develop  a  system  for  the  diagnosis  and  the  post-treatment  clinical follow-up  of  various  brain  disorders  and  illnesses,  including  ADHD,  concussions,  pain, rehabilitation after stroke, and more: this will enable correct decisions to be made based on direct measurement of the activity in the organ being treated – the brain.

Back to top